{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:15:29Z","timestamp":1784546129569,"version":"3.55.0"},"reference-count":120,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-040485"],"award-info":[{"award-number":["INV-040485"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Chronic tuberculosis (TB) disease, which requires months-long chemotherapy with multiple antibiotics, is defined by diverse pathological manifestations and bacterial phenotypes. Targeting drug-tolerant bacteria in the host is critical to achieving a faster and durable cure for TB. In order to facilitate this field of research, we need to consider the physiology of persistent MTB during infection, which is often associated with the nonreplicating (NR) state. However, the traditional approach to quantifying bacterial burden through colony enumeration alone only informs on the abundance of live bacilli at the time of sampling, and provides an incomplete picture of the replicative state of the pathogen and the extent to which bacterial replication is balanced by ongoing cell death. Modern approaches to profiling bacterial replication status provide a better understanding of inter- and intra-population dynamics under different culture conditions and in distinct host microenvironments. While some methods use molecular markers of DNA replication and cell division, other approaches take advantage of advances in the field of microfluidics and live-cell microscopy. Considerable effort has been made over the past few decades to develop preclinical in vivo models of TB infection and some are recognized for more closely recapitulating clinical disease pathology than others. Unique lesion compartments presenting different environmental conditions produce significant heterogeneity between <jats:italic>Mycobacterium tuberculosis<\/jats:italic> populations within the host. While cellular lesion compartments appear to be more permissive of ongoing bacterial replication, caseous foci are associated with the maintenance of <jats:italic>M<\/jats:italic>. <jats:italic>tuberculosis<\/jats:italic> in a state of static equilibrium. The accurate identification of nonreplicators and where they hide within the host have significant implications for the way novel chemotherapeutic agents and regimens are designed for persistent infections.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012595","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:22:58Z","timestamp":1728494578000},"page":"e1012595","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular and microbiological methods for the identification of nonreplicating Mycobacterium tuberculosis"],"prefix":"10.1371","volume":"20","author":[{"given":"Jansy Passiflora","family":"Sarathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"3","key":"ppat.1012595.ref001","article-title":"Persistent Bacterial Infections, Antibiotic Treatment Failure, and Microbial Adaptive Evolution.","volume":"11","author":"R La Rosa","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"ppat.1012595.ref002","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/acsinfecdis.3c00189","article-title":"Small-Molecule Antibiotic Drug Development","volume":"9","author":"M Bergkessel","year":"2023","journal-title":"Need and Challenges. ACS Infect Dis"},{"issue":"1","key":"ppat.1012595.ref003","doi-asserted-by":"crossref","DOI":"10.3390\/ph11010014","article-title":"Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions.","volume":"11","author":"DJ Cabral","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"ppat.1012595.ref004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","article-title":"Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise","volume":"12","author":"AK Coussens","year":"2024","journal-title":"Lancet Respir Med"},{"key":"ppat.1012595.ref005","volume-title":"A color atlas of comparative pathology of pulmonary tuberculosis.","author":"FJ Leong","year":"2011"},{"issue":"4","key":"ppat.1012595.ref006","first-page":"365","article-title":"Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities","volume":"44","author":"RL Hunter","year":"2014","journal-title":"Ann Clin Lab Sci"},{"key":"ppat.1012595.ref007","doi-asserted-by":"crossref","first-page":"820134","DOI":"10.3389\/fimmu.2022.820134","article-title":"In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses.","volume":"13","author":"MR Cronan","year":"2022","journal-title":"Front Immunol."},{"issue":"7","key":"ppat.1012595.ref008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201000079","article-title":"Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism","volume":"2","author":"MJ Kim","year":"2010","journal-title":"EMBO Mol Med"},{"issue":"8","key":"ppat.1012595.ref009","doi-asserted-by":"crossref","first-page":"e1007223","DOI":"10.1371\/journal.ppat.1007223","article-title":"Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific","volume":"14","author":"V Guerrini","year":"2018","journal-title":"PLoS Pathog"},{"issue":"9","key":"ppat.1012595.ref010","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/AAC.00276-07","article-title":"Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910","volume":"51","author":"AJ Lenaerts","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ppat.1012595.ref011","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/AAC.00115-15","article-title":"A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets","volume":"59","author":"LE Via","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ppat.1012595.ref012","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.00217-12","article-title":"Evaluation of a mouse model of necrotic granuloma formation using C3HeB\/FeJ mice for testing of drugs against Mycobacterium tuberculosis","volume":"56","author":"ER Driver","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ppat.1012595.ref013","doi-asserted-by":"crossref","first-page":"e17550","DOI":"10.1371\/journal.pone.0017550","article-title":"Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment","volume":"6","author":"DR Hoff","year":"2011","journal-title":"PLoS ONE"},{"issue":"8","key":"ppat.1012595.ref014","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1084\/jem.20180518","article-title":"Impact of immunopathology on the antituberculous activity of pyrazinamide","volume":"215","author":"L Blanc","year":"2018","journal-title":"J Exp Med"},{"key":"ppat.1012595.ref015","article-title":"Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations","author":"J Sarathy","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ppat.1012595.ref016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"PL Lin","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"ppat.1012595.ref017","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-065X.2010.00984.x","article-title":"Mycobacterium tuberculosis and the intimate discourse of a chronic infection","volume":"240","author":"DG Russell","year":"2011","journal-title":"Immunol Rev"},{"issue":"2","key":"ppat.1012595.ref018","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0020-2015","article-title":"Chronic Bacterial Pathogens: Mechanisms of Persistence.","volume":"4","author":"MX Byndloss","year":"2016","journal-title":"Microbiol Spectr."},{"issue":"2","key":"ppat.1012595.ref019","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0966-842X(02)00038-0","article-title":"The basis of persistent bacterial infections","volume":"11","author":"M Rhen","year":"2003","journal-title":"Trends Microbiol"},{"issue":"3","key":"ppat.1012595.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00159-19","article-title":"Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.","volume":"33","author":"JP Sarathy","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"ppat.1012595.ref021","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"VA Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"ppat.1012595.ref022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/acsinfecdis.1c00570","article-title":"Identification of beta-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions","volume":"8","author":"B Gold","year":"2022","journal-title":"ACS Infect Dis"},{"issue":"1","key":"ppat.1012595.ref023","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0031-2016","article-title":"Targeting Phenotypically Tolerant Mycobacterium tuberculosis.","volume":"5","author":"B Gold","year":"2017","journal-title":"Microbiol Spectr"},{"key":"ppat.1012595.ref024","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3389\/fmicb.2020.01248","article-title":"Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases","volume":"11","author":"L Lopez Quezada","year":"2020","journal-title":"Front Microbiol"},{"issue":"12","key":"ppat.1012595.ref025","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/acsinfecdis.5b00025","article-title":"Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis","volume":"1","author":"T Warrier","year":"2015","journal-title":"ACS Infect Dis"},{"issue":"10","key":"ppat.1012595.ref026","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/cb4004817","article-title":"Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model","volume":"8","author":"SS Grant","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"7","key":"ppat.1012595.ref027","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/cb2004884","article-title":"A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis","volume":"7","author":"PA Mak","year":"2012","journal-title":"ACS Chem Biol"},{"issue":"2","key":"ppat.1012595.ref028","doi-asserted-by":"crossref","first-page":"e0059823","DOI":"10.1128\/mbio.00598-23","article-title":"A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. Tuberculosis found","volume":"14","author":"JP Sarathy","year":"2023","journal-title":"Caseum. mBio"},{"key":"ppat.1012595.ref029","doi-asserted-by":"crossref","first-page":"1085946","DOI":"10.3389\/fcimb.2022.1085946","article-title":"Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis","volume":"12","author":"T Greenstein","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"ppat.1012595.ref030","article-title":"Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis.","volume":"7","author":"SER Gibson","year":"2018","journal-title":"Pathogens"},{"issue":"12","key":"ppat.1012595.ref031","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122334","article-title":"Mycobacterium tuberculosis Dormancy: How to Fight a Hidden Danger.","volume":"10","author":"EG Salina","year":"2022","journal-title":"Microorganisms"},{"issue":"3","key":"ppat.1012595.ref032","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S1517-838246320140507","article-title":"Dormancy models for Mycobacterium tuberculosis: A minireview","volume":"46","author":"AM Alnimr","year":"2015","journal-title":"Braz J Microbiol"},{"issue":"1","key":"ppat.1012595.ref033","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/IAI.73.1.546-551.2005","article-title":"Replication dynamics of Mycobacterium tuberculosis in chronically infected mice","volume":"73","author":"EJ Munoz-Elias","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"ppat.1012595.ref034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.1915","article-title":"A replication clock for Mycobacterium tuberculosis","volume":"15","author":"WP Gill","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"ppat.1012595.ref035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"KN Adams","year":"2011","journal-title":"Cell"},{"issue":"16","key":"ppat.1012595.ref036","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1128\/JB.00452-09","article-title":"igr Genes and Mycobacterium tuberculosis cholesterol metabolism","volume":"191","author":"JC Chang","year":"2009","journal-title":"J Bacteriol"},{"issue":"3","key":"ppat.1012595.ref037","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: myths, models, and molecular mechanisms","volume":"78","author":"NK Dutta","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"ppat.1012595.ref038","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fcimb.2019.00272","article-title":"Resuscitation of Dormant \"Non-culturable\" Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst.","volume":"9","author":"EG Salina","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"ppat.1012595.ref039","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"M Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"ppat.1012595.ref040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tube.2016.05.006","article-title":"Defining dormancy in mycobacterial disease","volume":"99","author":"S Lipworth","year":"2016","journal-title":"Tuberculosis (Edinb)."},{"issue":"24","key":"ppat.1012595.ref041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413317","article-title":"Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review).","volume":"22","author":"A Egorova","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"3","key":"ppat.1012595.ref042","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"LE Connolly","year":"2007","journal-title":"PLoS Med"},{"key":"ppat.1012595.ref043","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fmicb.2017.00717","article-title":"Animal Models for Tuberculosis in Translational and Precision Medicine.","volume":"8","author":"L Zhan","year":"2017","journal-title":"Front Microbiol"},{"issue":"3","key":"ppat.1012595.ref044","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0034-2017","article-title":"Preclinical Efficacy Testing of New Drug Candidates.","volume":"5","author":"EL Nuermberger","year":"2017","journal-title":"Microbiol Spectr."},{"key":"ppat.1012595.ref045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000323633","article-title":"Chapter 15: The Role of the Mouse Model in the Evaluation of New Antituberculosis Drugs.","volume":"40","author":"E. Nuermberger","year":"2011","journal-title":"Antituberculosis Chemotherapy"},{"issue":"6","key":"ppat.1012595.ref046","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tube.2012.07.003","article-title":"Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis","volume":"92","author":"SG Franzblau","year":"2012","journal-title":"Tuberculosis (Edinb)."},{"issue":"1","key":"ppat.1012595.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12010049","article-title":"Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell.","volume":"12","author":"P Soldevilla","year":"2022","journal-title":"Pathogens"},{"key":"ppat.1012595.ref048","doi-asserted-by":"crossref","first-page":"613149","DOI":"10.3389\/fcimb.2021.613149","article-title":"One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.","volume":"11","author":"HJ Yang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ppat.1012595.ref049","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"JL Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"ppat.1012595.ref050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.micinf.2005.10.033","article-title":"Lessons from experimental Mycobacterium tuberculosis infections","volume":"8","author":"JL Flynn","year":"2006","journal-title":"Microbes Infect"},{"issue":"6","key":"ppat.1012595.ref051","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"LG Wayne","year":"1996","journal-title":"Infect Immun"},{"issue":"4","key":"ppat.1012595.ref052","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis","volume":"51","author":"SH Cho","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ppat.1012595.ref053","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"JC Betts","year":"2002","journal-title":"Mol Microbiol"},{"issue":"4","key":"ppat.1012595.ref054","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01092-17","article-title":"The Capacity of Mycobacterium tuberculosis To Survive Iron Starvation Might Enable It To Persist in Iron-Deprived Microenvironments of Human Granulomas.","volume":"8","author":"K Kurthkoti","year":"2017","journal-title":"MBio"},{"issue":"10","key":"ppat.1012595.ref055","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/AAC.00821-10","article-title":"Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis","volume":"54","author":"C Sala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ppat.1012595.ref056","doi-asserted-by":"crossref","first-page":"e0038123","DOI":"10.1128\/aac.00381-23","article-title":"ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate","volume":"67","author":"M Xie","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1012595.ref057","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fmicb.2020.00359","article-title":"Extreme Drug Tolerance of Mycobacterium abscessus \"Persisters\".","volume":"11","author":"YK Yam","year":"2020","journal-title":"Front Microbiol"},{"issue":"110016","key":"ppat.1012595.ref058","article-title":"Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response.","volume":"1","author":"S Subbian","year":"2011","journal-title":"Open Biol"},{"issue":"8","key":"ppat.1012595.ref059","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/AAC.00531-12","article-title":"Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.","volume":"56","author":"LE Via","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ppat.1012595.ref060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0962-8479(97)90016-2","article-title":"Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis","volume":"78","author":"ER Rhoades","year":"1997","journal-title":"Tuber Lung Dis"},{"issue":"6","key":"ppat.1012595.ref061","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1242\/dmm.019570","article-title":"Presence of multiple lesion types with vastly different microenvironments in C3HeB\/FeJ mice following aerosol infection with Mycobacterium tuberculosis","volume":"8","author":"SM Irwin","year":"2015","journal-title":"Dis Model Mech"},{"issue":"9","key":"ppat.1012595.ref062","doi-asserted-by":"crossref","first-page":"e1002944","DOI":"10.1371\/journal.ppat.1002944","article-title":"Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish.","volume":"8","author":"M Parikka","year":"2012","journal-title":"PLoS Pathog"},{"issue":"140","key":"ppat.1012595.ref063","doi-asserted-by":"crossref","DOI":"10.3791\/58299-v","article-title":"Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish.","author":"H Luukinen","year":"2018","journal-title":"J Vis Exp"},{"issue":"11","key":"ppat.1012595.ref064","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1128\/IAI.00887-06","article-title":"Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity","volume":"74","author":"LE Swaim","year":"2006","journal-title":"Infect Immun"},{"issue":"2","key":"ppat.1012595.ref065","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum","volume":"62","author":"JP Sarathy","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ppat.1012595.ref066","first-page":"83","article-title":"Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts","volume":"42","author":"RJ Rees","year":"1961","journal-title":"Br J Exp Pathol"},{"issue":"2","key":"ppat.1012595.ref067","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0003-2015","article-title":"Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox.","volume":"5","author":"C Vilcheze","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"2","key":"ppat.1012595.ref068","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"I Kramnik","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"10","key":"ppat.1012595.ref069","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1128\/IAI.71.10.6004-6011.2003","article-title":"Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis","volume":"71","author":"YC Manabe","year":"2003","journal-title":"Infect Immun"},{"key":"ppat.1012595.ref070","first-page":"8","article-title":"Persistent Mycobacterium tuberculosis infection in mice requires PerM for successful cell division","author":"R Wang","year":"2019","journal-title":"Elife"},{"issue":"6","key":"ppat.1012595.ref071","doi-asserted-by":"crossref","first-page":"e1002769","DOI":"10.1371\/journal.ppat.1002769","article-title":"Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection","volume":"8","author":"KH Rohde","year":"2012","journal-title":"PLoS Pathog"},{"issue":"4","key":"ppat.1012595.ref072","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20172020","article-title":"Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny","volume":"215","author":"L Huang","year":"2018","journal-title":"J Exp Med"},{"issue":"5","key":"ppat.1012595.ref073","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/nar\/gkj514","article-title":"Bacterial single-stranded DNA-binding proteins are phosphorylated on tyrosine","volume":"34","author":"I Mijakovic","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"ppat.1012595.ref074","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2008.01.044","article-title":"Independent positioning and action of Escherichia coli replisomes in live cells","volume":"133","author":"R Reyes-Lamothe","year":"2008","journal-title":"Cell"},{"issue":"1","key":"ppat.1012595.ref075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2958.2006.05356.x","article-title":"Spatial and temporal organization of the Bacillus subtilis replication cycle","volume":"62","author":"MB Berkmen","year":"2006","journal-title":"Mol Microbiol"},{"issue":"9","key":"ppat.1012595.ref076","doi-asserted-by":"crossref","first-page":"e1004394","DOI":"10.1371\/journal.ppat.1004394","article-title":"Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection","volume":"10","author":"N Sukumar","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1012595.ref077","first-page":"e1010459","volume":"18","author":"RC Lavin","year":"2022","journal-title":"Spatial relationships of intra-lesion heterogeneity in Mycobacterium tuberculosis microenvironment"},{"key":"ppat.1012595.ref078","doi-asserted-by":"crossref","first-page":"43836","DOI":"10.1038\/srep43836","article-title":"Multifork chromosome replication in slow-growing bacteria.","volume":"7","author":"D Trojanowski","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"ppat.1012595.ref079","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00739-19","article-title":"Watching DNA Replication Inhibitors in Action: Exploiting Time-Lapse Microfluidic Microscopy as a Tool for Target-Drug Interaction Studies in Mycobacterium","volume":"63","author":"D Trojanowski","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"ppat.1012595.ref080","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/ncomms3470","article-title":"Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria","volume":"4","author":"I Santi","year":"2013","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1012595.ref081","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12915-017-0465-4","article-title":"Investigating the physiology of viable but non-culturable bacteria by microfluidics and time-lapse microscopy.","volume":"15","author":"RA Bamford","year":"2017","journal-title":"BMC Biol."},{"issue":"1","key":"ppat.1012595.ref082","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","article-title":"Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms","volume":"17","author":"G Manina","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"1","key":"ppat.1012595.ref083","doi-asserted-by":"crossref","first-page":"19578","DOI":"10.1038\/s41598-022-24175-9","article-title":"Microfluidic dose-response platform to track the dynamics of drug response in single mycobacterial cells.","volume":"12","author":"M Mistretta","year":"2022","journal-title":"Sci Rep."},{"key":"ppat.1012595.ref084","doi-asserted-by":"crossref","first-page":"968342","DOI":"10.3389\/fbioe.2022.968342","article-title":"Microfluidics for long-term single-cell time-lapse microscopy: Advances and applications.","volume":"10","author":"P Allard","year":"2022","journal-title":"Front Bioeng Biotechnol."},{"issue":"11","key":"ppat.1012595.ref085","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9112330","article-title":"Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery.","volume":"9","author":"A Molloy","year":"2021","journal-title":"Microorganisms"},{"issue":"6064","key":"ppat.1012595.ref086","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1216166","article-title":"Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility","volume":"335","author":"BB Aldridge","year":"2012","journal-title":"Science"},{"issue":"5690","key":"ppat.1012595.ref087","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1126\/science.1099390","article-title":"Bacterial persistence as a phenotypic switch","volume":"305","author":"NQ Balaban","year":"2004","journal-title":"Science"},{"key":"ppat.1012595.ref088","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41378-021-00262-1","article-title":"Development of single-cell-level microfluidic technology for long-term growth visualization of living cultures of Mycobacterium smegmatis","volume":"7","author":"H Wang","year":"2021","journal-title":"Microsyst Nanoeng"},{"key":"ppat.1012595.ref089","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-0716-1460-0_8","article-title":"Single-Cell Analysis of Mycobacteria Using Microfluidics and Time-Lapse Microscopy.","volume":"2314","author":"G Manina","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"6","key":"ppat.1012595.ref090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tube.2012.06.006","article-title":"A microfluidic system for long-term time-lapse microscopy studies of mycobacteria","volume":"92","author":"SA Golchin","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"ppat.1012595.ref091","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41378-020-0164-0","article-title":"Microfluidics for interrogating live intact tissues.","volume":"6","author":"LF Horowitz","year":"2020","journal-title":"Microsyst Nanoeng"},{"issue":"6252","key":"ppat.1012595.ref092","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aac4812","article-title":"Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples","volume":"349","author":"T Korem","year":"2015","journal-title":"Science"},{"issue":"11","key":"ppat.1012595.ref093","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nrmicro2202","article-title":"Metabolism, cell growth and the bacterial cell cycle","volume":"7","author":"JD Wang","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ppat.1012595.ref094","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/s41467-021-22833-6","article-title":"Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens","volume":"12","author":"ND Walter","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"ppat.1012595.ref095","doi-asserted-by":"crossref","first-page":"e0058321","DOI":"10.1128\/AAC.00583-21","article-title":"Comparative Analysis of Pharmacodynamics in the C3HeB\/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832","volume":"65","author":"GT Robertson","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"ppat.1012595.ref096","doi-asserted-by":"crossref","first-page":"e0028423","DOI":"10.1128\/aac.00284-23","article-title":"Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses","volume":"67","author":"ND Walter","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ppat.1012595.ref097","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells","volume":"12","author":"V. Dartois","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ppat.1012595.ref098","first-page":"9","article-title":"A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth","author":"VV Thacker","year":"2020","journal-title":"Elife"},{"key":"ppat.1012595.ref099","first-page":"6","article-title":"Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells","author":"D Mahamed","year":"2017","journal-title":"Elife"},{"issue":"7","key":"ppat.1012595.ref100","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/2211-5463.13537","article-title":"High content quantitative imaging of Mycobacterium tuberculosis responses to acidic microenvironments within human macrophages","volume":"13","author":"B Aylan","year":"2023","journal-title":"FEBS Open Bio"},{"issue":"5","key":"ppat.1012595.ref101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/ijmr.IJMR_554_18","article-title":"Animal models of tuberculosis: Lesson learnt","volume":"147","author":"AK Singh","year":"2018","journal-title":"Indian J Med Res"},{"issue":"4","key":"ppat.1012595.ref102","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB\/FeJ Mice.","volume":"2","author":"SM Irwin","year":"2016","journal-title":"ACS Infect Dis."},{"issue":"6","key":"ppat.1012595.ref103","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1242\/dmm.019513","article-title":"Heterogeneous disease progression and treatment response in a C3HeB\/FeJ mouse model of tuberculosis","volume":"8","author":"JP Lanoix","year":"2015","journal-title":"Dis Model Mech"},{"issue":"435","key":"ppat.1012595.ref104","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7786","article-title":"Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data","volume":"10","author":"D Rifat","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"ppat.1012595.ref105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"B Prideaux","year":"2015","journal-title":"Nat Med"},{"key":"ppat.1012595.ref106","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.202.Supp.190.41","article-title":"Deciphering multicellular microenvironment of tuberculosis lung granulomas associated with bacterial control using high-throughput single-cell mRNA sequencing","volume":"202","author":"H Gideon","year":"2019","journal-title":"J Immunol"},{"key":"ppat.1012595.ref107","volume-title":"The tubercle bacillus in the pulmonary lesion of man.","author":"G. Canetti","year":"1955"},{"issue":"6","key":"ppat.1012595.ref108","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S1473-3099(20)30148-1","article-title":"Cavitary tuberculosis: the gateway of disease transmission","volume":"20","author":"ME Urbanowski","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ppat.1012595.ref109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.201311-2106PP","article-title":"Tuberculosis, pulmonary cavitation, and matrix metalloproteinases","volume":"190","author":"CW Ong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"ppat.1012595.ref110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.47.3.833-836.2003","article-title":"Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary","volume":"47","author":"J. Grosset","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ppat.1012595.ref111","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"CB Ford","year":"2011","journal-title":"Nat Genet"},{"key":"ppat.1012595.ref112","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1099\/00221287-148-10-2951","article-title":"Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum.","volume":"148","author":"NJ Garton","year":"2002","journal-title":"Microbiol-Sgm."},{"issue":"4","key":"ppat.1012595.ref113","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.pmed.0050075","article-title":"Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.","volume":"5","author":"NJ Garton","year":"2008","journal-title":"PLoS Med."},{"issue":"11","key":"ppat.1012595.ref114","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence","volume":"4","author":"P Peyron","year":"2008","journal-title":"PLoS Pathog"},{"issue":"9","key":"ppat.1012595.ref115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"DG Russell","year":"2009","journal-title":"Nat Immunol"},{"key":"ppat.1012595.ref116","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3389\/fmicb.2017.02681","article-title":"Ultrastructural Analysis of Cell Envelope and Accumulation of Lipid Inclusions in Clinical Mycobacterium tuberculosis Isolates from Sputum, Oxidative Stress, and Iron Deficiency.","volume":"8","author":"S Vijay","year":"2017","journal-title":"Front Microbiol."},{"issue":"6","key":"ppat.1012595.ref117","doi-asserted-by":"crossref","first-page":"e6077","DOI":"10.1371\/journal.pone.0006077","article-title":"A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.","volume":"4","author":"C Deb","year":"2009","journal-title":"PLoS ONE"},{"issue":"2","key":"ppat.1012595.ref118","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/IAI.01196-13","article-title":"Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis","volume":"82","author":"I Caire-Brandli","year":"2014","journal-title":"Infect Immun"},{"issue":"5","key":"ppat.1012595.ref119","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/mmi.13422","article-title":"The perilipin-like PPE15 protein in Mycobacterium tuberculosis is required for triacylglycerol accumulation under dormancy-inducing conditions","volume":"101","author":"J Daniel","year":"2016","journal-title":"Mol Microbiol"},{"issue":"6","key":"ppat.1012595.ref120","doi-asserted-by":"crossref","first-page":"e1002093","DOI":"10.1371\/journal.ppat.1002093","article-title":"Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages","volume":"7","author":"J Daniel","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:23:25Z","timestamp":1728494605000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012595"}},"subtitle":[],"editor":[{"given":"Antje","family":"Blumenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":120,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012595","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}